Trillium Therapeutics Inc.

Pharmaceutical company · Mississauga, Ontario, Canada

Trillium Therapeutics Inc. is a pharmaceutical company headquartered in Mississauga, Ontario, Canada. It has reported private securities offerings to the US SEC, most recently $20 million sold in a notice filed in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

Trillium Therapeutics at a glance

Typepharmaceutical company
HeadquartersMississauga, Ontario, Canada
SEC industryPharmaceutical Preparations
SEC CIK1616212

What does Trillium Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $20 million sold (2017).

Frequently asked questions about Trillium Therapeutics

Where is Trillium Therapeutics headquartered?

Trillium Therapeutics Inc. is headquartered in Mississauga, Ontario, Canada.

What does Trillium Therapeutics do?

Trillium Therapeutics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences